BATS BZX Real-Time Price
As of 3:08pm ET
| -0.17 / -6.54%|
The 1 analysts offering 12-month price forecasts for Orexigen Therapeutics Inc have a median target of 4.00, with a high estimate of 4.00 and a low estimate of 4.00. The median estimate represents a +64.61% increase from the last price of 2.43.
The current consensus among 1 polled investment analysts is to Hold stock in Orexigen Therapeutics Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.